Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS Pharmaceutical's quarterly buildings and improvements
declined
from Aug. 2025 ($1,708 Mil) to Nov. 2025 ($1,653 Mil) but then
increased
from Nov. 2025 ($1,653 Mil) to Feb. 2026 ($1,686 Mil).
COSMOS Pharmaceutical's annual buildings and improvements
increased
from May. 2024 ($2,022 Mil) to May. 2025 ($2,437 Mil) and
increased
from May. 2025 ($2,437 Mil) to May. 2026 ($2,485 Mil).
COSMOS Pharmaceutical Buildings And Improvements Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Buildings And Improvements can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Buildings And Improvements Chart
COSMOS Pharmaceutical Buildings And Improvements Calculation
Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.
Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.
What does a Buildings And Improvements of $1,686 Mil mean?
COSMOS Pharmaceutical (CSMYF) has a Buildings And Improvements of $1,686 Mil as of Feb. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on COSMOS Pharmaceutical and its competitors.
Is COSMOS Pharmaceutical's Buildings And Improvements too high?
COSMOS Pharmaceutical's current Buildings And Improvements is $1,686 Mil. Overall, COSMOS Pharmaceutical has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Buildings And Improvements compare to competitors?
COSMOS Pharmaceutical's Buildings And Improvements of $1,686 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Healthcare Providers & Services company?
A good Buildings And Improvements depends on the Healthcare Providers & Services industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on COSMOS Pharmaceutical and its competitors. COSMOS Pharmaceutical's current Buildings And Improvements is $1,686 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
COSMOS Pharmaceutical (CSMYF) has a current Buildings And Improvements of $1,686 Mil. The stock's GF Value™ is $48.62, compared to a current price of $37.06 — trading 23.8% below its estimated fair value. The current Buildings And Improvements is $1,686 Mil. COSMOS Pharmaceutical's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Buildings And Improvements is $1,686 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 23.8% below its estimated GF Value™ of $48.62.
Key valuation signals for CSMYF:
Buildings And Improvements: $1,686 Mil
GF Value™: $48.62 vs. price of $37.06 (23.8% below fair value)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
78GF Score
Get the complete analysis for CSMYF
Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
